[Delirium in the 'young' covid-19 patient (65 years): preliminary clinical indications]
Autor: | DI GIACOMO E., COLMEGNA F., SANTORELLI M., PESSINA R., D'AMICO E., MARCATILI M., DAKANALIS A., PAVONE F., FAGIOLINI A., CLERICI Massimo. |
---|---|
Přispěvatelé: | DI GIACOMO, E, Colmegna, F, Santorelli, M, Pessina, R, D'Amico, E, Marcatili, M, Dakanalis, A, Pavone, F, Fagiolini, A, Clerici, M |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Rivista di psichiatria. 56(2) |
ISSN: | 2038-2502 |
Popis: | Delirium is a phenomenon classified within neuro-cognitive disorders in the DSM-5. It has several etiologies and it is often lethal. This contribute aims at analyzing clinical characteristics and diagnostic possibilities of delirium in patients affected by covid-19. Furthermore, some preliminary recommendations on the use of psychopharmacological treatment of delirium and their interactions with main drugs used to treat covid-19 are given, with a special attention to comorbidities like in immunocompromised patients, in those affected by diabetes and cancer, in pregnant women or in addicted clients. |
Databáze: | OpenAIRE |
Externí odkaz: |